Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma
(Q68891168)
scientific article published on 01 September 1990
scientific article published on 01 September 1990
Language:
other details
description | scientific article published on 01 September 1990 |
External Links
(P356) |
10.1093/JNCI/82.17.1397
|
(P698) |
2388289
|